Introduction Individuals experiencing moderate to severe mental illness have low rates of workforce inclusion, with a consequence of high welfare dependency, affecting both societal costs and health.

When you become aware of the time consumed by creating one slide deck is typically when you start looking for more efficient ways of working, which is also when using a free AI PowerPoint presentation ...

Introduction Onchocerciasis, commonly known as river blindness, is a parasitic disease caused by Onchocerca volvulus affecting millions predominantly in sub-Saharan Africa. Robust epidemiological ...

"Depression please cut to the chase." by darcyadelaide is marked with CC BY 2.0. As Politico reported, in 2018 the nonprofit also launched a for-profit spinoff called Loris.ai, which planned to use ...

Every day, millions of people input prompts (whether questions or instructions) into AI tools such as ChatGPT, Perplexity, Claude, DALL-E, or Meta AI. Recently, media coverage highlighted what seemed ...

A feasibility study analyzes all of the critical aspects of a proposed project. Understand how these studies work, how to conduct them, and the benefits involved.

Rezolute, Inc., a company focused on treating hypoglycemia caused by hyperinsulinism, announced that its abstract for a Phase 3 study of its drug Ersodetug will be presented at ENDO 2025 in San ...

This case presents an 80-year-old male with a history of Alzheimer’s disease who was hospitalized due to a frequent dry cough. A 16-slice computed tomography examination of the chest revealed multiple ...

CSA, a pending 501(c)(3) nonprofit, is the brainchild of Leo Seigal, founder and CEO of the interior design matchmaking consultancy The Expert, and entrepreneur Dustin Bramell, whose own LA midcentury ...

Creating a presentation can feel like a daunting task, especially when you’re juggling tight deadlines or trying to bring a creative vision to life. We’ve all been there—staring at a blank slide, ...

aTyr Pharma, Inc. announced it will present three posters at the American Thoracic Society (ATS) 2025 International Conference in San Francisco, showcasing its lead candidate efzofitimod, currently ...